https://litfl.com/intraosseous-access/

The Paradigm Shift from Passive Tools to Intelligent Systems

Subcutaneous injection needles are undergoing a paradigm shift from "generic devices" to "personalized solutions". The intelligent needle system integrates multiple sensors, enabling the needle to have sensing capabilities. The fiber Bragg grating sensor measures the needle strain with a resolution of 0.1 mm and identifies tissue types through strain patterns: fat tissue strain is gentle (<100 με), fascia layer strain changes abruptly (200-300 με), and the vascular wall has pulsatile strain. The impedance spectrum sensor applies 10 kHz-1 MHz alternating current at the needle tip and identifies tissues through impedance changes: blood impedance is approximately 150 Ω·cm, muscle is approximately 300 Ω·cm, and fat is approximately 2000 Ω·cm. The temperature sensor has an accuracy of ±0.1℃ and can detect an inflammatory temperature rise of 0.5℃. After the data from these sensors are fused, a real-time tissue map of the puncture path can be constructed.

The Painless Technology Breakthroughs

The painless technology has made breakthroughs in multiple aspects. The vibration analgesic device integrates micro piezoelectric ceramics, generating micro vibrations with a frequency of 100-150 Hz and an amplitude of 0.05-0.1 mm. These vibrations suppress pain transmission through gating theory. Clinical trials showed that the VAS pain score of the vibration group decreased from 3.2 ± 1.1 of the control group to 1.5 ± 0.8 (p < 0.01). Temperature pre-treatment heats the needle to 34°C, eliminating the temperature difference with the skin (typically 8-10°C) and avoiding activation of temperature receptors. Surface anesthesia pre-treatment only takes 15 seconds: the needle tip dips into microcapsules of local anesthetic (particle size 5-10 μm), releases them instantly upon insertion into the skin, and takes effect in 2-3 seconds. Pulsed electric fields form an electric field at the needle insertion front, reversibly changing the membrane potential of nerve cells and blocking signal transmission for 0.5-1 second, sufficient to complete the puncture.

The New Material Revolution

The new material revolution is underway. Biodegradable magnesium alloy needles (WE43 series) completely degrade in the body within 3 to 6 months, with the degradation products being magnesium ions and hydrogen gas. The former promotes bone healing, while the latter can be absorbed. Shape-memory polymer needles bend at body temperature, allowing them to bypass obstacles and reach the target point. Afterward, they return to a straight state for easy removal. Liquid metal needles (gallium-based alloy) are in a liquid state at room temperature and solidify after injection and can be used for embolization treatment. The most advanced is the bio-hybrid needle: cells from the patient are grown on the surface of the biodegradable needle to form an active interface, reducing foreign body reactions. Self-healing needles release repair agents at micro-cracks, extending their lifespan by 5 to 10 times.

Micro-Nano Manufacturing Technology

Micro-nano manufacturing technology creates new forms. The micro-needle array is a disruptive design: 100 to 1,000 micro-needles with a length of 200 to 800 μm are arranged on a 1 cm² substrate, penetrating the stratum corneum but not exceeding the dermal layer where the pain-sensing nerve endings are located. The inner diameter of the hollow micro-needle is 10 to 50 μm, enabling continuous infusion; the solid micro-needle is coated with drugs, which dissolve in the stratum corneum; the coated micro-needle has its surface loaded with drugs, which are released after insertion. 3D printing enables personalization: curved needles printed based on a patient's MRI data can precisely reach target points that traditional straight needles cannot reach. Four-dimensional printing is more intelligent: the needle shape changes under body temperature or a specific pH, such as unfolding barbs when entering the tumor microenvironment (pH 6.5 - 7.0) to prevent detachment.

Integrated Precise Drug Delivery System

The closed-loop system continuously monitors blood sugar and automatically injects insulin, increasing the rate of achieving the target level of glycosylated hemoglobin from 30% in traditional treatment to 70%. The targeted delivery system integrates magnetic-responsive materials at the needle tip and gathers at the target tissue under the guidance of an external magnetic field, increasing the local drug concentration by 10 to 100 times. The pulse release system releases drugs on demand through the periodic melting of phase-change material valves by a micro-heating element. The most intelligent aspect is the "sensing-decision-execution" integrated system: continuously monitors multiple biomarkers, calculates the optimal drug delivery plan through algorithms, and automatically performs the injection, advancing chronic disease treatment from "standardized plans" to "personalized dynamic adjustment".

These technological breakthroughs have transformed subcutaneous injection needles from simple mechanical tools into intelligent medical terminals, opening up new treatment models in areas such as diabetes management, tumor treatment, immune regulation, and neurological diseases. They represent the future direction of the deep integration of medical devices with biotechnology, information technology, and materials science.